Growing transplant procedures, expanding healthcare infrastructure, and innovation in organ preservation technologies drive an 8.31% CAGR from 2026 to 2035…
Company Showcases SteraMist iHP Automation to Industry Giants Including Amgen, Merck, and Moderna; Finalizes Custom Engineering Contract for Proprietary Healthcare…
Program provides access to leronlimab for patients with limited treatment options while supporting ongoing clinical development VANCOUVER, Washington, April 27,…